As of Aug 18
| +0.016 / +4.17%|
The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 17.40, with a high estimate of 17.40 and a low estimate of 17.40. The median estimate represents a +4,250.00% increase from the last price of 0.40.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.